aon glp-1 study Weight loss drugs can help employers cut health care costs, says GLP-1s come with high upfront

31% of GLP-1 users drank less alcohol in the past year

But how does semaglutide stack up against the first-ever weight loss medication, phentermine

The GLP-1 receptor agonist market is experiencing significant growth, driven by the increasing prevalence of type 2 diabetes and obesity, and the high...

Morning sickness during pregnancy

I'm writing this first post in a series about the payer/provider relationship because this should be interesting to every hospital system in Mass - the ripple effects create more exposure than they realize

For users this could segway into an expansion of the private market and for payers this could provide an affordable entry point for public reimbursement